Literature DB >> 90571

Lymphocyte response to phytohaemagglutinin in the presence of serum from pregnant women: correlation with serum levels of alpha-foetoprotein.

M A Figueredo, P Palomino, F Ortiz.   

Abstract

The effect of sera from women in different stages of pregnancy on cultures of human lymphocytes stimulated with phytohaemagglutinin (PHA) has been studied and correlated with alpha-foetoprotein (AFP) levels. Sera taken before the twentieth week of gestation showed low levels of AFP and failed to inhibit lymphocyte proliferation. Inhibition was obtained with 38.5% of sera taken from weeks 20 to 30 and with 51.7% of sera after the thirtieth week of pregnancy. Average serum levels of AFP also increased with advanced gestation, but a consistent correlation was not found between AFP concentration and inhibitory activity for every individual serum tested. Lymphocytes from pregnant women or from normal blood donors behaved in the same way in these tests. The mechanisms of inhibition and the role of AFP are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90571      PMCID: PMC1537680     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Estrogen-binding properties of rat, mouse and man fetospecific serum proteins. Demonstration by immuno-autoradiographic methods.

Authors:  J Uriel; B de Nechaud; M Dupiers
Journal:  Biochem Biophys Res Commun       Date:  1972-02-16       Impact factor: 3.575

2.  Depressed maternal lymphocyte response to phytohaemagglutinin in human pregnancy.

Authors:  D T Purtilo; H M Hallgren; E J Yunis
Journal:  Lancet       Date:  1972-04-08       Impact factor: 79.321

3.  Cellular immune aspects of the human fetal maternal relationship. II. In vitro response of gravida lymphocytes to phytohemagglutinin.

Authors:  M C Carr; D P Stites; H H Fudenberg
Journal:  Cell Immunol       Date:  1973-09       Impact factor: 4.868

4.  Peripheral blood lymphocyte responses to phytohemagglutinin and pokeweed mitogen during pregnancy.

Authors:  C C Hsu
Journal:  Proc Soc Exp Biol Med       Date:  1974-07

5.  Augmentation of proliferation of human mixed lymphocyte culture by human alpha-fetoprotein.

Authors:  B Charpentier; R D Guttmann; J Shuster; P Gold
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

6.  Inhibition of human lymphocyte transformation by human alpha-foetoprotein (HAFP); comparison of foetal and hepatoma HAFP and kinetic studies in vitro immunosuppression.

Authors:  S Yachnin; E Lester
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

7.  The immunosuppressive role of alpha-fetoprotein during pregnancy.

Authors:  R A Murgita
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

8.  Determination of alpha-fetoprotein by a new paper disc radioimmunoassay of the sandwich type.

Authors:  S G Johansson; B Kjessler; M S Sherman
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

9.  Demonstration of the inhibitory effect of human alpha-fetoprotein on in vitro transformation of human lymphocytes.

Authors:  S Yachnin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

10.  Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response.

Authors:  R A Murgita; T B Tomasi
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

View more
  3 in total

1.  The occurrence and properties of E rosette inhibitory substance in the sera of malnourished children.

Authors:  L S Salimonu; A O Johnson; A I Williams; G I Adeleye; B O Osunkoya
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

2.  Response of human peripheral blood lymphocytes in the presence of cord sera: relationship of lymphocyte transformation with number of pregnancies and levels of alpha-fetoprotein.

Authors:  M Wajner; S S Papiha; T I Wagstaff
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

3.  Polyamine-polyamine oxidase interaction: part of maternal protective mechanism against fetal rejection.

Authors:  D M Morgan; G Illei
Journal:  Br Med J       Date:  1980-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.